☆ 4.7 Article

All Infants Are at Risk of Developing Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection and Deserve Protection

JOURNAL OF INFECTIOUS DISEASES (2022)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018

Chelsea L. Hansen et al.

Summary: This study evaluated excess mortality from RSV and influenza in the US from 1999 to 2018, finding that RSV poses a greater risk to infants while influenza is associated with substantial mortality among elderly individuals.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Immunology

The Use of Death Certificate Data to Characterize Mortality Associated With Respiratory Syncytial Virus, Unspecified Bronchiolitis, and Influenza in the United States, 1999-2018

Chelsea L. Hansen et al.

Summary: This study analyzed death certificate data from 1999 to 2018 to understand the mortality burden associated with RSV and influenza. The findings showed that RSV and bronchiolitis deaths primarily occurred in children under 1 year old, while influenza deaths were more common in adults aged 65 and above. The study also found that infants were more likely to die outside of the hospital from respiratory pathogens compared to other causes, and race/ethnicity alone did not explain this disparity.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Respiratory Syncytial Virus During the COVID-19 Pandemic Compared to Historic Levels: A Retrospective Cohort Study of a Health System

Naimisha Movva et al.

Summary: The research showed significant changes in the incidence of respiratory syncytial virus (RSV) respiratory infections in infants during COVID-19, with different patterns across various healthcare settings, and the emergence of interseasonal disease. It is important to continue monitoring the epidemiology of RSV to understand its impact on healthcare resources and public health policy.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Review Immunology

Mortality Among US Infants and Children Under 5 Years of Age with Respiratory Syncytial Virus and Bronchiolitis: A Systematic Literature Review

Lauren C. Bylsma et al.

Summary: A systematic literature review was conducted to summarize the mortality rates of US infants and children aged <5 years with respiratory syncytial virus (RSV) or all-cause bronchiolitis (ACB). The study found that the reported RSV mortality rates vary greatly and there is a need for nationally representative estimates for otherwise healthy, late-preterm to full-term infants and children.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample

Mina Suh et al.

Summary: This study demonstrates that acute bronchiolitis due to RSV is the leading cause of hospitalizations in US infants, especially during the winter months.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011-2019

Mina Suh et al.

Summary: This study highlights the importance of ensuring access to RSV preventive measures for all infants and reveals the rates and trends of RSV hospitalizations and emergency department visits among infants with different insurance types.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Review Immunology

Impact of Respiratory Syncytial Virus on Child, Caregiver, and Family Quality of Life in the United States: Systematic Literature Review and Analysis( )

Elizabeth L. Glaser et al.

Summary: This study systematically reviewed and analyzed the burden of illness from respiratory syncytial virus (RSV) among infants. The results indicated that RSV reduces the quality of life of children, caregivers, and families. However, the existing data mainly focus on hospitalized premature infants, and more research is needed for full-term healthy children.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model

Alexia Kieffer et al.

Summary: Universal immunization with nirsevimab for all infants could greatly reduce the health and economic burden of RSV during their first season, including a decrease in RSV-related illnesses, hospitalizations, and cost savings.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Review Immunology

Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age

Naimisha Movva et al.

Summary: This systematic literature review examines RSV testing patterns and finds that not all infants and children with LRTI are tested for RSV, leading to an underestimation of the RSV burden in all settings.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Review Immunology

A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year( )

Mina Suh et al.

Summary: A systematic review of studies on respiratory syncytial virus (RSV) and bronchiolitis in US infants revealed substantial variability in the burden and healthcare utilization rates. Nationally representative studies are needed to understand the impact of RSV and healthcare utilization.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020

Jason R. Gantenberg et al.

Summary: RSV is a major cause of infant hospitalization in the United States. While preterm infants and those with specific comorbidities are at high risk, 80% of RSV infections occur in term infants without comorbidities. Future prevention efforts should target all infants.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Review Immunology

Cost of Respiratory Syncytial Virus Infections in US Infants: Systematic Literature Review and Analysis

Diana M. Bowser et al.

Summary: This study examines the economic costs of respiratory syncytial virus (RSV) infections among infants and young children in the United States. The findings suggest that public sources bear the majority of the medical costs associated with infants' RSV treatment, and full-term infants account for the majority of RSV hospitalizations and costs.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States

Gabriela B. Gomez et al.

Summary: The target populations and financing mechanisms for a new health technology may affect health inequalities in access and impact. Using alternative reimbursement pathway scenarios, we projected the distributional consequences of introducing nirsevimab for prevention of respiratory syncytial virus. The vaccine pathway would cover 32% more infants than a pharmaceutical pathway and have greater benefits in reducing hospitalizations and emergency room visits, especially for publicly insured infants.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Mortality Associated With Respiratory Syncytial Virus, Bronchiolitis, and Influenza Among Infants in the United States: A Birth Cohort Study From 1999 to 2018

Heidi Reichert et al.

Summary: This study describes the mortality rate of infants in the United States due to respiratory syncytial virus (RSV). The highest mortality rates were observed among infants with a gestational age of less than 29 weeks, American Indian/Alaskan Native infants, and Medicaid-insured infants. However, the burden of RSV mortality was greatest in full-term infants, white infants, and Medicaid-insured infants.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Infectious Diseases

Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries

Lisa Staadegaard et al.

Summary: The study found that RSV epidemics mainly occur in winter in most temperate countries, lasting 10-21 weeks. More variation in seasonality was observed in (sub)tropical countries, with substantial differences at a subnational level. There was no clear association between epidemic timing and the dominant RSV subtype.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021

Sonja J. Olsen et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Respiratory syncytial virus-associated deaths in the United States according to death certificate data, 2005 to 2016

Mila M. Prill et al.

Summary: In the United States, RSV-associated deaths have been on the rise over the past decade, especially since 2013, primarily due to an increase in RSV-associated pneumonia deaths among older adults.

HEALTH SCIENCE REPORTS (2021)

Add to Collection

Article Immunology

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

Gabriel Rainisch et al.

VACCINE (2020)

Add to Collection

Article Virology

Seasonality of Respiratory Viral Infections

Miyu Moriyama et al.

ANNUAL REVIEW OF VIROLOGY, VOL 7, 2020 (2020)

Add to Collection

Editorial Material Medicine, General & Internal

The Vaccines for Children Program at 25-Access, Affordability, and Sustainability

Jason L. Schwartz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Pediatrics

Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016

Brian Rha et al.

PEDIATRICS (2020)

Add to Collection

Article Infectious Diseases

Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15

Carmen S. Arriola et al.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Respiratory Syncytial Virus Seasonality - United States, 2014-2017

Erica Billig Rose et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)

Add to Collection

Article Public, Environmental & Occupational Health

Prevalence of infant bronchiolitis-coded healthcare encounters attributable to RSV

Kedir N. Turi et al.

HEALTH SCIENCE REPORTS (2018)

Add to Collection

Article Microbiology

Environmental Drivers of the Spatiotemporal Dynamics of Respiratory Syncytial Virus in the United States

Virginia E. Pitzer et al.

PLOS PATHOGENS (2015)

Add to Collection

Article Pediatrics

Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis

Shawn L. Ralston et al.

PEDIATRICS (2014)

Add to Collection

Article Pediatrics

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

Michael T. Brady et al.

PEDIATRICS (2014)

Add to Collection

Article Pediatrics

Respiratory Syncytial Virus-Associated Hospitalizations Among Children Less Than 24 Months of Age

Caroline Breese et al.

PEDIATRICS (2013)

Add to Collection

Article Pharmacology & Pharmacy

Respiratory Syncytial Virus Testing During Bronchiolitis Episodes of Care in an Integrated Health Care Delivery System: A Retrospective Cohort Study

Valerie Flaherman et al.

CLINICAL THERAPEUTICS (2010)

Add to Collection

Article Medicine, General & Internal

Mortality associated with influenza and respiratory syncytial virus in the United States

WW Thompson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

Add to Collection

Article Pediatrics

Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000

S Leader et al.

JOURNAL OF PEDIATRICS (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.